LoginSignup
immagine del profilo
Bimbam
@Klambam
1Anno·

Has anyone read news about $IBRX (+1,21%) or knows what is going on? Almost 300% in one month.

1
11 Commenti
immagine del profilo
Patrick ₿ateman@fastlane
1Anno
„NATIONAL MULTICENTER TRIAL OPENS TO STUDY IMMUNITYBIO'S TRI-AD5 CANCER
VACCINES PLUS N-803 TO PREVENT CANCER IN PEOPLE WITH LYNCH SYNDROME“ - Reuters
•
2
•
immagine del profilo
Yassin@RisingAktie
1Anno
Wanted to expand my position the other day when they were at just under € 2, but then they were already slowly shooting up again. Stupid timing until the money was on deposit :(
•
2
•
immagine del profilo
Bimbam@Klambam
1Anno
@RisingAktie Did not dare to buy again 😂
••
immagine del profilo
Yassin@RisingAktie
1Anno
@Klambam I thought the go down again briefly, but then it knew only one direction upwards and I wanted to reduce my buy-in actually and not increase. Well, I'm just now well back in the plus. Could only have been more, if I had decided 1-2 days earlier
••
immagine del profilo
Bimbam@Klambam
1Anno
@RisingAktie yes let's wait and see where the journey goes 💪🏻
•
1
•
immagine del profilo
Nico@itZNico
1Anno
"The increase in share prices is likely due to the positive momentum building around the company's lead pipeline candidate, N-803. The FDA is currently reviewing a regulatory submission for N-803 in combination with Bacillus Calmette-Guerin (BGC) for the treatment of patients with bladder cancer." Source: https://www.zacks.com/stock/news/2091284/immunitybio-ibrx-stock-jumps-432-will-it-continue-to-soar
•
1
•
immagine del profilo
Bimbam@Klambam
1Anno
@Clermit that did not run with as hoped. rebuy? 😂
•
1
•
immagine del profilo
MarsEquities@CircusClown
1Anno
@Klambam 😑das timing was of course pure comedy . Have been holding for ages and bought some more during and before the run and sold ~1/5 of the position at 5-6 again. Now again -40% all time with the rest . I personally buy rather between 1-1.5 after if it comes so far yet. Since there is no new date I suspect that it will take at least 3-6 months until the next decision, so it has for me no particular hurry to buy if it is not just again at the 52w low rumdümpelt. Of course only my personal opinion
•
2
•
immagine del profilo
MarsEquities@CircusClown
1Anno
What the others have already mentioned + general strength in biotech in recent weeks + insider buying in April by Soon-Shiong. IBRX was also sold off massively before that. YTD it is still "only" 22% up.
••
immagine del profilo
MarsEquities@CircusClown
1Anno
@Clermit shovel stocks is unfortunately no longer here but on his Twitter he regularly posts updates about IBRX.
•
2
•
immagine del profilo
Bimbam@Klambam
1Anno
@Clermit ah okay, thanks for the info 👍🏻
••
Partecipa alla conversazione
IscrivitiAccesso